These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Initial retroviral drug with new mechanism of action. Peptide T-20 enriches therapeutic arsenal]. MMW Fortschr Med; 2003 Apr; 145 Spec No 1():55-7. PubMed ID: 15011591 [No Abstract] [Full Text] [Related]
11. [HIV-1 fusion inhibitor improves treatment in HIV-1-resistant patients]. Blasko M Dtsch Med Wochenschr; 2003 May; 128(19):1032. PubMed ID: 12774800 [No Abstract] [Full Text] [Related]
12. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor. Cervia JS; Smith MA Clin Infect Dis; 2003 Oct; 37(8):1102-6. PubMed ID: 14523775 [TBL] [Abstract][Full Text] [Related]
13. Enfuvirtide, an HIV-1 fusion inhibitor. Jenny-Avital ER N Engl J Med; 2003 Oct; 349(18):1770-1; author reply 1770-1. PubMed ID: 14593994 [No Abstract] [Full Text] [Related]
14. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Matthews T; Salgo M; Greenberg M; Chung J; DeMasi R; Bolognesi D Nat Rev Drug Discov; 2004 Mar; 3(3):215-25. PubMed ID: 15031735 [TBL] [Abstract][Full Text] [Related]
15. [Fusion inhibitor enfuvirtidE. Continuous virologic and immunologic response]. Schäfer B MMW Fortschr Med; 2005 Apr; 147 Spec No 1():31. PubMed ID: 16385869 [No Abstract] [Full Text] [Related]
16. US FDA approves new class of HIV therapeutics. Robertson D Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558 [No Abstract] [Full Text] [Related]
17. [First fusion inhibitor is available. No entry for HIV-1 viruses]. MMW Fortschr Med; 2003 Jun; 145(25):51. PubMed ID: 12891854 [No Abstract] [Full Text] [Related]
18. HIV entry inhibitors: a new generation of antiretroviral drugs. Krambovitis E; Porichis F; Spandidos DA Acta Pharmacol Sin; 2005 Oct; 26(10):1165-73. PubMed ID: 16174430 [TBL] [Abstract][Full Text] [Related]
19. HIV genetic mutations causing resistance to the new drug T-20: recent findings. Bean P Am Clin Lab; 2002 Oct; 21(8):15-6. PubMed ID: 12440170 [No Abstract] [Full Text] [Related]
20. Discontinuation of the clinical development of fusion inhibitor T-1249. Martin-Carbonero L AIDS Rev; 2004; 6(1):61. PubMed ID: 15168742 [No Abstract] [Full Text] [Related] [Next] [New Search]